BIOGEN INC Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BIOGEN INC, and what generic alternatives to BIOGEN INC drugs are available?
BIOGEN INC has three approved drugs.
There are seventeen US patents protecting BIOGEN INC drugs.
There are two hundred and twenty patent family members on BIOGEN INC drugs in forty-two countries and forty-seven supplementary protection certificates in thirteen countries.
Summary for BIOGEN INC
| International Patents: | 220 |
| US Patents: | 17 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
| PTAB Cases with BIOGEN INC as patent owner: | See PTAB cases with BIOGEN INC as patent owner |
Drugs and US Patents for BIOGEN INC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biogen Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-001 | Mar 27, 2013 | AB | RX | Yes | No | 10,994,003 | ⤷ Sign Up | ⤷ Sign Up | |||
| Biogen Inc | ZURZUVAE | zuranolone | CAPSULE;ORAL | 217369-001 | Oct 31, 2023 | RX | Yes | No | 10,342,810 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Biogen Inc | ZURZUVAE | zuranolone | CAPSULE;ORAL | 217369-003 | Oct 31, 2023 | RX | Yes | Yes | 11,884,696 | ⤷ Sign Up | ⤷ Sign Up | ||||
| Biogen Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-001 | Mar 27, 2013 | AB | RX | Yes | No | 10,391,160 | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for BIOGEN INC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Biogen Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-002 | Mar 27, 2013 | 8,759,393 | ⤷ Sign Up |
| Biogen Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-001 | Mar 27, 2013 | 6,509,376 | ⤷ Sign Up |
| Biogen Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-001 | Mar 27, 2013 | 8,759,393 | ⤷ Sign Up |
| Biogen Inc | TECFIDERA | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 204063-001 | Mar 27, 2013 | 7,803,840 | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for BIOGEN INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-releaseCapsules | 120 mg and 240 mg | ➤ Subscribe | 2017-03-27 |
International Patents for BIOGEN INC Drugs
Supplementary Protection Certificates for BIOGEN INC Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1131065 | 92488 | Luxembourg | ⤷ Sign Up | PRODUCT NAME: DIMETHYL FUMARATE. FIRST REGISTRATION: 20140130 |
| 2137537 | 310 5015-2014 | Slovakia | ⤷ Sign Up | PRODUCT NAME: DIMETYLFUMARAT; REGISTRATION NO/DATE: EU/1/13/837/001 - EU/1/13/837/002 20140203 |
| 2653873 | C202330003 | Spain | ⤷ Sign Up | PRODUCT NAME: DIMETILFUMARATO; NATIONAL AUTHORISATION NUMBER: EU/1/13/837; DATE OF AUTHORISATION: 20140130; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/13/837; DATE OF FIRST AUTHORISATION IN EEA: 20140130 |
| 2970101 | 8/2022 | Austria | ⤷ Sign Up | PRODUCT NAME: DIROXIMELFUMARAT; NAT. REGISTRATION NO/DATE: EU/1/21/1585 (MITTEILUNG) 20211116; FIRST REGISTRATION: LI 68066 (CH) 20210920 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
